A 23‐Gene Classifier urine test for prostate cancer prognosis
Open Access
- 1 March 2021
- journal article
- letter
- Published by Wiley in Clinical and Translational Medicine
- Vol. 11 (3), e340
- https://doi.org/10.1002/ctm2.340
Abstract
No abstract availableFunding Information
- Sanming Project of Medicine in Shenzhen (SZSM201412014)
- Cancerfonden (CAN2017/381)
This publication has 10 references indexed in Scilit:
- Development and validation of a 25-Gene Panel urine test for prostate cancer diagnosis and potential treatment follow-upBMC Medicine, 2020
- Diagnostic and Prognostic MicroRNA Biomarkers for Prostate Cancer in Cell-free UrineEuropean Urology Focus, 2018
- A Panel of Biomarkers for Diagnosis of Prostate Cancer Using Urine SamplesAnticancer Research, 2018
- A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized DiseaseEuropean Urology, 2018
- Individual Patient-Level Meta-Analysis of the Performance of the Decipher Genomic Classifier in High-Risk Men After Prostatectomy to Predict Development of Metastatic DiseaseJournal of Clinical Oncology, 2017
- Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisionsProstate Cancer and Prostatic Diseases, 2016
- Use of two gene panels for prostate cancer diagnosis and patient risk stratificationTumor Biology, 2016
- Prognostic Utility of the Cell Cycle Progression Score Generated from Biopsy in Men Treated with ProstatectomyJournal of Urology, 2014
- Multi-institutional Validation of the CAPRA-S Score to Predict Disease Recurrence and Mortality After Radical ProstatectomyEuropean Urology, 2013
- Preoperative Nomogram Predicting the 10-Year Probability of Prostate Cancer Recurrence After Radical ProstatectomyJNCI Journal of the National Cancer Institute, 2006